Choose your screen resolution: Auto adjust 800x600 1024x768

Information

Login

Lost Password?
No account yet? Register

Please Visit

Advertisement

Study shows rituximab effective in treating chronic graft-versus-host disease

PDF Print

Study shows rituximab effective in treating chronic graft-versus-host disease A study by Dana-Farber researchers offers the strongest evidence yet of the effectiveness of a novel therapy for chronic graft-versus-host disease (GVHD), a potentially life-threatening complication of donor bone marrow and stem cell transplants.

Read more (http://e2ma.net/go/239768086/192517/5516379/goto:http://www.dana-farber.org/abo/news/press/2006/study-shows-rituximab-effective-in-treating-chronic-graft-versus-host-disease.html)

Search This Site

Tax Deductible Donation

Please support this site and online support for health challenges of all kinds, which are provided by the Online Patient Empowerment Project, a 501(c)(3) Corporation.

Search the Web

Google

Mailing Lists

Have you subscribed to the MMA interactive mailing list?  Please click HERE to subscribe. Once subscribed, you can choose a daily digest version, real time delivery and you'll have access to the list archives. To join the ACOR list, please click HERE.

Syndicate

Statistics

Visitors: 693037

Who's Online